TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
AEterna Zentaris GmbH; Centre National de la Recherche Scientifique; University of Montpellier I; University of Montpellier II
US Patent
AEterna Zentaris GmbH; Centre National de la Recherche Scientifique; University of Montpellier I; University of Montpellier II
US Patent
Affinity DataIC50: 0.600nMAssay Description:Competitive binding assay using ghrelin receptor.More data for this Ligand-Target Pair
Affinity DataIC50: 1nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
Affinity DataIC50: 1nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
Affinity DataIC50: 1nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
Affinity DataIC50: 1nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
Affinity DataIC50: 1nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
Affinity DataIC50: 1nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
AEterna Zentaris GmbH; Centre National de la Recherche Scientifique; University of Montpellier I; University of Montpellier II
US Patent
AEterna Zentaris GmbH; Centre National de la Recherche Scientifique; University of Montpellier I; University of Montpellier II
US Patent
Affinity DataIC50: 1.30nMAssay Description:Competitive binding assay using ghrelin receptor.More data for this Ligand-Target Pair
TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
AEterna Zentaris GmbH; Centre National de la Recherche Scientifique; University of Montpellier I; University of Montpellier II
US Patent
AEterna Zentaris GmbH; Centre National de la Recherche Scientifique; University of Montpellier I; University of Montpellier II
US Patent
Affinity DataIC50: 1.40nMAssay Description:Competitive binding assay using ghrelin receptor.More data for this Ligand-Target Pair
Affinity DataIC50: 2nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
Affinity DataIC50: 2nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
Affinity DataIC50: 2nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
Affinity DataIC50: 2nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
Affinity DataIC50: 2nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
Affinity DataIC50: 3nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
AEterna Zentaris GmbH; Centre National de la Recherche Scientifique; University of Montpellier I; University of Montpellier II
US Patent
AEterna Zentaris GmbH; Centre National de la Recherche Scientifique; University of Montpellier I; University of Montpellier II
US Patent
Affinity DataIC50: 3nMAssay Description:Competitive binding assay using ghrelin receptor.More data for this Ligand-Target Pair
Affinity DataIC50: 3nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
Affinity DataIC50: 3nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
Affinity DataIC50: 3nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
Affinity DataIC50: 3nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
Affinity DataIC50: 3nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
AEterna Zentaris GmbH; Centre National de la Recherche Scientifique; University of Montpellier I; University of Montpellier II
US Patent
AEterna Zentaris GmbH; Centre National de la Recherche Scientifique; University of Montpellier I; University of Montpellier II
US Patent
Affinity DataIC50: 3.20nMAssay Description:Competitive binding assay using ghrelin receptor.More data for this Ligand-Target Pair
TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
AEterna Zentaris GmbH; Centre National de la Recherche Scientifique; University of Montpellier I; University of Montpellier II
US Patent
AEterna Zentaris GmbH; Centre National de la Recherche Scientifique; University of Montpellier I; University of Montpellier II
US Patent
Affinity DataIC50: 3.40nMAssay Description:Competitive binding assay using ghrelin receptor.More data for this Ligand-Target Pair
TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
AEterna Zentaris GmbH; Centre National de la Recherche Scientifique; University of Montpellier I; University of Montpellier II
US Patent
AEterna Zentaris GmbH; Centre National de la Recherche Scientifique; University of Montpellier I; University of Montpellier II
US Patent
Affinity DataIC50: 3.40nMAssay Description:Competitive binding assay using ghrelin receptor.More data for this Ligand-Target Pair
Affinity DataIC50: 4nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
Affinity DataIC50: 4nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
Affinity DataIC50: 4nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
Affinity DataIC50: 4nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
Affinity DataIC50: 4nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
Affinity DataIC50: 4nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
Affinity DataIC50: 5nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
Affinity DataIC50: 5nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
Affinity DataIC50: 5nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
Affinity DataIC50: 5nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
Affinity DataIC50: 6nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
Affinity DataIC50: 6nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
Affinity DataIC50: 6nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
Affinity DataIC50: 6nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
Affinity DataIC50: 6nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
Affinity DataIC50: 6nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
Affinity DataIC50: 6nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
Affinity DataIC50: 6nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
AEterna Zentaris GmbH; Centre National de la Recherche Scientifique; University of Montpellier I; University of Montpellier II
US Patent
AEterna Zentaris GmbH; Centre National de la Recherche Scientifique; University of Montpellier I; University of Montpellier II
US Patent
Affinity DataIC50: 8.60nMAssay Description:Competitive binding assay using ghrelin receptor.More data for this Ligand-Target Pair
TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
AEterna Zentaris GmbH; Centre National de la Recherche Scientifique; University of Montpellier I; University of Montpellier II
US Patent
AEterna Zentaris GmbH; Centre National de la Recherche Scientifique; University of Montpellier I; University of Montpellier II
US Patent
Affinity DataIC50: 16.5nMAssay Description:Competitive binding assay using ghrelin receptor.More data for this Ligand-Target Pair
Affinity DataIC50: 24nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
Affinity DataIC50: 39nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
Affinity DataIC50: 41nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
![](/img/powered_by_small.gif)